Using the SEER-Medicare database, we found negative association between Medicare claim processors“related physician's chemotherapy reimbursement and their prescription of granulocyte colony-stimulating factor for non-Hodgkin lymphoma patients.
Usha Sambamoorthi, PhD
Advertisement
Articles by Usha Sambamoorthi, PhD
Advertisement
Latest Updated Articles
- Medicare Claim Processors' Reimbursement and G-CSF Choice Among Non-Hodgkin Lymphoma Patients
Published: August 21st 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Earlier Menopause, Reduced Cardiac Function Potentially Linked With Negative Impacts on Brain Health
2
A Multifaceted Approach to Navigating Career Transitions in Pharmacy
3
FDA Approves Elinzanetant as First Nonhormonal Therapy for Menopause Vasomotor Symptoms
4
Menopause Care Varies by Provider, Highlighting Need for Standardized Education
5
